Doctors and Scientists Write to the European Medicines Agency, Warning of COVID-19 Vaccine Dangers for a Third Time

Ahead of European Green Certificate (vaccine passport) vote in the European Parliament on April 28, the experts warn that cardinal symptoms of cerebral venous sinus thrombosis (CVST) dominate the list of adverse reactions to COVID-19 vaccines- Doctors for Covid EthicsApr

Doctors for Covid EthicsApr 24·4 min read

For the urgent personal attention of Emer Cooke, Executive Director of the European Medicines Agency

Emer Cooke, Executive Director, European Medicines Agency, Amsterdam, The Netherlands, 20 April 2021

BY EMAIL ONLY

Dear Sirs/Mesdames,

FOR THE URGENT PERSONAL ATTENTION OF EMER COOKE, EXECUTIVE DIRECTOR OF THE EUROPEAN MEDICINES AGENCY

The European Medicines Agency and those persons who work for that regulatory body, of which body you are Executive Director, were put on notice by Doctors for Covid Ethics on 1 April 2021.

We note your iterations to the press since that date.

Our concerns re the gene-based vaccines are not confined to that of Astra-Zeneca, rather to all the COVID-19 gene-based vaccines, namely those of Astra-Zeneca, Pfizer, Moderna and Johnson & Johnson.

1a. Our most serious concern re ALL the gene-based vaccines is that you convey the impression that cerebral venous sinus thrombosis (CVST) is a very rare adverse event. In fact the opposite is probably true. The cardinal symptoms of CVST dominate the list of adverse reactions:

piercing headache

nausea and vomiting

impaired consciousness

impaired speech

impaired vision

impaired hearing

paralysis of varying degrees in various locations

loss of motor control (including such severe loss that victims mimic the symptoms of Huntington’s Chorea).

It is imperative that proper medical attention is given to every individual who presents with any of the above symptoms.

It is the indirigible duty of the European Medicines Agency to disseminate the above information to medical doctors and responsible authorities.

1b. A further serious concern is that peripheral “clot” formation is not alluded to by you at all.

It is evident that “clot” formation in the deep veins of the legs and arms can lead to life-threatening pulmonary embolism.

1c. Further, thrombus formation in the small vessels of the lungs can lead to a clinical picture resembling atypical pneumonia.

1d. In addition, it is vitally important to understand that any one of 1a. 1b. 1c. or any combination of these can lead via consumption of coagulation factors to the clinical picture of disseminated intravascular coagulation (DIC) which is actually characterised by massive bleeding events into the skin and into other organs of the body.

It is imperative that all the above diagnoses are actively searched for and that all cases displaying symptoms consistent with any of these diagnoses are recorded properly as adverse vaccine-related events.

1e. Furthermore, long term adverse effects, in particular the danger of immune dependant enhancement of disease and adverse effects of subsequent vaccinations are impossible to predict.

The European Medicines Agency, as the regulator re vaccines for almost 450 million people across 27 European Union member states, must inform the public and the relevant authorities of this profoundly important issue.

2. We believe that the number of deaths due to the gene-based vaccines to which you have publicly admitted is but a small percentage of the actual number of deaths due to the gene-based vaccines.

3. With regard to 2. we suspect that death certificates a